Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Short-read (Illumina) 16S-EZ - For genus/species identification of bacteria and archaea - Targeted sequencing of 16S rRNA gene (V3 & V4 regions) - Short-read (Illumina) Full Length 16S - For ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

175-700 bp for libraries prepared using the Illumina Nextera™ or Illumina Nextera™ XT Library Preparation methods. ~570-600 bp for libraries prepared for 16S amplicon sequencing of the V3-V4 rRNA ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools, sending shares down ...